Drugs / oxyhydrogen nanobubble
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT07466381 | Nov 2024 → Nov 2025 | Parkinson disease | dr. Siti Nurlaela, SpN | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | oxyhydrogen nanobubble | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07466381 ↗ |